Mandate

Vinge advisor to the lead investors in connection with Kry’s USD 300m financing round

The financing round was led by CPP Investments (CPPIB) and Fidelity Management & Research Company LLC with participation from existing investors, including the Ontario Teachers’ Pension Plan, Index Ventures, Accel, Creandum and Project A.

Vinge has acted as lead counsel to the lead investors CPP Investments (CPPIB) and Fidelity Management & Research Company LLC in connection with the financing round.

 

Kry will use the investment to scale its platform, building on both its operations as a healthcare provider and its innovative software offerings as well as further geographic expansion. This will bring the benefits of its technology to millions more patients across Europe. Kry, which has been growing rapidly since it was founded in 2015, has helped over three million patients access healthcare to date.

 

The company grew over 100% year-on-year in 2020 in response to supporting patients and healthcare systems across Europe during the pandemic. The new funding will help the company meet the increasing patient demand for their virtual healthcare services and fulfil its vision of making high-quality healthcare accessible for all.

 

Vinge’s team included partners Johan Larsson and Matthias Pannier, together with Karl Klackenberg, Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Mathilda Persson and Karl-Hugo Engdahl (IT & Data Protection) and Sara Strandberg (Employment).  

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025